Echocardiographic Markers of Prognosis in Patients Undergoing Ventricular Arrhythmia Ablation
In patients undergoing RFA for VAs, several echocardiographic measures may identify patients at risk of an adverse outcome.
Authors
- Morten Lock Hansen (ORCID: https://orcid.org/0000-0001-7996-5005)
- René Worck (ORCID: https://orcid.org/0000-0001-9501-6168)
- Martin Huth Ruwald (ORCID: https://orcid.org/0000-0002-1541-309X)
- Lisa Steen Duus (ORCID: https://orcid.org/0000-0003-4110-3199)
- Maria Dons (ORCID: https://orcid.org/0000-0003-3506-6862)
- Tor Biering‐Sørensen (ORCID: https://orcid.org/0000-0003-4209-2778)
- Arne Johannessen
- Jim Hansen
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
Publication Details
- Journal
- Echocardiography
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1111/echo.70307
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- AstraZeneca
- Sanofi
- Boston Scientific Corporation
- Novo Nordisk
- Seqirus
- Sanofi Pasteur